← Leaderboards
Roni Shouval
Sloan-Kettering Inst Can Research
$833,055
Attributed
$833,055
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $277.7K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$833,055 · 1
By mechanism
K08$833,055 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Sohrab P Shah$4,881,319
- Ronglai Shen$3,190,387
- Timothy An-Thy Chan$21,076,830
- Matthew Frank Buas$3,813,510
- John Thomas Poirier$4,490,380
Others in their field
Other Rising Stars on “Antigens”
- Jason Dickens · Duke University$12,259,409
- Warwick Britton · University Of Sydney$10,964,476
- Suma Babu · Massachusetts General Hospital$9,673,541
- Sabrina Paganoni · Massachusetts General Hospital$9,673,541
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Philip Felgner · University Of California-Irvine$9,134,165
Research focus
AntigensAutologousAutomobile DrivingB-Cell LymphomasBcl2 GeneBiobankBioinformaticsBiological MarkersBiologyBiomarker DiscoveryBiomarker IdentificationBiopsyCancer CellCar T Cell TherapyCd19 GeneCell Death InductionCellsCell TherapyCessation Of LifeChimeric Antigen Receptor T CellsClinical Decision-MakingCodeCohortAcquired Treatment Resistance
Grant awards (3)
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells$277,685
K08 · FY2025 · CA · contact PI
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells$277,685
K08 · FY2024 · CA · contact PI
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells$277,685
K08 · FY2023 · CA · contact PI